Selected research
Market Structure
Global Therapeutic Drug Monitoring Consumables Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Therapeutic Drug Monitoring Consumables market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Therapeutic Drug Monitoring Consumables is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Therapeutic Drug Monitoring Consumables is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Therapeutic Drug Monitoring Consumables is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Therapeutic Drug Monitoring Consumables is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Therapeutic Drug Monitoring Consumables include Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Sekisui Medical Co., Ltd, Exagen Inc, Danaher Corporation, Bio-Rad Laboratories and bioMérieux SA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Therapeutic Drug Monitoring Consumables market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Therapeutic Drug Monitoring Consumables and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Therapeutic Drug Monitoring Consumables sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Therapeutic Drug Monitoring Consumables market size, projected growth trends, production technologies, key applications, and end-use industries.
Therapeutic Drug Monitoring Consumables Segment by Company
Abbott Laboratories
Thermo Fisher Scientific
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Sekisui Medical Co., Ltd
Exagen Inc
Danaher Corporation
Bio-Rad Laboratories
bioMérieux SA
Alere, Inc.
Therapeutic Drug Monitoring Consumables Segment by Type
Immunoassay Consumables
Chromatography & Mass Spectrometry Consumables
Therapeutic Drug Monitoring Consumables Segment by Application
Commercial & Private Laboratories
Research and Academic Institutes
Hospital Laboratories
Therapeutic Drug Monitoring Consumables Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Drug Monitoring Consumables market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Drug Monitoring Consumables and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Drug Monitoring Consumables.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Therapeutic Drug Monitoring Consumables market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic Drug Monitoring Consumables manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Therapeutic Drug Monitoring Consumables in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Therapeutic Drug Monitoring Consumables in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Immunoassay Consumables
- Chromatography & Mass Spectrometry Consumables
Applications
- Commercial & Private Laboratories
- Research and Academic Institutes
- Hospital Laboratories
Companies covered
- Abbott Laboratories
- Thermo Fisher Scientific
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers AG
- Sekisui Medical Co., Ltd
- Exagen Inc
- Danaher Corporation
- Bio-Rad Laboratories
- bioMérieux SA
- Alere, Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Therapeutic Drug Monitoring Consumables Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Therapeutic Drug Monitoring Consumables Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Therapeutic Drug Monitoring Consumables Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Therapeutic Drug Monitoring Consumables Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Therapeutic Drug Monitoring Consumables Market Dynamics
- 2.1 Therapeutic Drug Monitoring Consumables Industry Trends
- 2.2 Therapeutic Drug Monitoring Consumables Industry Drivers
- 2.3 Therapeutic Drug Monitoring Consumables Industry Opportunities and Challenges
- 2.4 Therapeutic Drug Monitoring Consumables Industry Restraints
3 Therapeutic Drug Monitoring Consumables Market by Manufacturers
- 3.1 Global Therapeutic Drug Monitoring Consumables Revenue by Manufacturers (2021-2026)
- 3.2 Global Therapeutic Drug Monitoring Consumables Sales by Manufacturers (2021-2026)
- 3.3 Global Therapeutic Drug Monitoring Consumables Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Therapeutic Drug Monitoring Consumables Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Therapeutic Drug Monitoring Consumables Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Therapeutic Drug Monitoring Consumables Manufacturers, Product Type & Application
- 3.7 Global Therapeutic Drug Monitoring Consumables Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Therapeutic Drug Monitoring Consumables Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Therapeutic Drug Monitoring Consumables Players Market Share by Revenue in 2025
- 3.8.3 2025 Therapeutic Drug Monitoring Consumables Tier 1, Tier 2, and Tier 3
4 Therapeutic Drug Monitoring Consumables Market by Type
- 4.1 Therapeutic Drug Monitoring Consumables Type Introduction
- 4.1.1 Immunoassay Consumables
- 4.1.2 Chromatography & Mass Spectrometry Consumables
- 4.2 Global Therapeutic Drug Monitoring Consumables Sales by Type
- 4.2.1 Global Therapeutic Drug Monitoring Consumables Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Therapeutic Drug Monitoring Consumables Sales by Type (2021-2032)
- 4.2.3 Global Therapeutic Drug Monitoring Consumables Sales Market Share by Type (2021-2032)
- 4.3 Global Therapeutic Drug Monitoring Consumables Revenue by Type
- 4.3.1 Global Therapeutic Drug Monitoring Consumables Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Therapeutic Drug Monitoring Consumables Revenue by Type (2021-2032)
- 4.3.3 Global Therapeutic Drug Monitoring Consumables Revenue Market Share by Type (2021-2032)
5 Therapeutic Drug Monitoring Consumables Market by Application
- 5.1 Therapeutic Drug Monitoring Consumables Application Introduction
- 5.1.1 Commercial & Private Laboratories
- 5.1.2 Research and Academic Institutes
- 5.1.3 Hospital Laboratories
- 5.2 Global Therapeutic Drug Monitoring Consumables Sales by Application
- 5.2.1 Global Therapeutic Drug Monitoring Consumables Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Therapeutic Drug Monitoring Consumables Sales by Application (2021-2032)
- 5.2.3 Global Therapeutic Drug Monitoring Consumables Sales Market Share by Application (2021-2032)
- 5.3 Global Therapeutic Drug Monitoring Consumables Revenue by Application
- 5.3.1 Global Therapeutic Drug Monitoring Consumables Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Therapeutic Drug Monitoring Consumables Revenue by Application (2021-2032)
- 5.3.3 Global Therapeutic Drug Monitoring Consumables Revenue Market Share by Application (2021-2032)
6 Global Therapeutic Drug Monitoring Consumables Sales by Region
- 6.1 Global Therapeutic Drug Monitoring Consumables Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Therapeutic Drug Monitoring Consumables Sales by Region (2021-2032)
- 6.2.1 Global Therapeutic Drug Monitoring Consumables Sales by Region (2021-2026)
- 6.2.2 Global Therapeutic Drug Monitoring Consumables Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Therapeutic Drug Monitoring Consumables Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Therapeutic Drug Monitoring Consumables Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Therapeutic Drug Monitoring Consumables Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Therapeutic Drug Monitoring Consumables Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Therapeutic Drug Monitoring Consumables Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Therapeutic Drug Monitoring Consumables Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Therapeutic Drug Monitoring Consumables Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Therapeutic Drug Monitoring Consumables Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Therapeutic Drug Monitoring Consumables Revenue by Region
- 7.1 Global Therapeutic Drug Monitoring Consumables Revenue by Region
- 7.1.1 Global Therapeutic Drug Monitoring Consumables Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Therapeutic Drug Monitoring Consumables Revenue by Region (2021-2026)
- 7.1.3 Global Therapeutic Drug Monitoring Consumables Revenue by Region (2027-2032)
- 7.1.4 Global Therapeutic Drug Monitoring Consumables Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Therapeutic Drug Monitoring Consumables Revenue (2021-2032)
- 7.2.2 North America Therapeutic Drug Monitoring Consumables Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Therapeutic Drug Monitoring Consumables Revenue (2021-2032)
- 7.3.2 Europe Therapeutic Drug Monitoring Consumables Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Therapeutic Drug Monitoring Consumables Revenue (2021-2032)
- 7.4.2 Asia-Pacific Therapeutic Drug Monitoring Consumables Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Therapeutic Drug Monitoring Consumables Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Therapeutic Drug Monitoring Consumables Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Company Information
- 8.1.2 Abbott Laboratories Business Overview
- 8.1.3 Abbott Laboratories Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott Laboratories Therapeutic Drug Monitoring Consumables Product Portfolio
- 8.1.5 Abbott Laboratories Recent Developments
- 8.2 Thermo Fisher Scientific
- 8.2.1 Thermo Fisher Scientific Company Information
- 8.2.2 Thermo Fisher Scientific Business Overview
- 8.2.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Scientific Therapeutic Drug Monitoring Consumables Product Portfolio
- 8.2.5 Thermo Fisher Scientific Recent Developments
- 8.3 F. Hoffmann-La Roche Ltd
- 8.3.1 F. Hoffmann-La Roche Ltd Company Information
- 8.3.2 F. Hoffmann-La Roche Ltd Business Overview
- 8.3.3 F. Hoffmann-La Roche Ltd Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 F. Hoffmann-La Roche Ltd Therapeutic Drug Monitoring Consumables Product Portfolio
- 8.3.5 F. Hoffmann-La Roche Ltd Recent Developments
- 8.4 Siemens Healthineers AG
- 8.4.1 Siemens Healthineers AG Company Information
- 8.4.2 Siemens Healthineers AG Business Overview
- 8.4.3 Siemens Healthineers AG Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Siemens Healthineers AG Therapeutic Drug Monitoring Consumables Product Portfolio
- 8.4.5 Siemens Healthineers AG Recent Developments
- 8.5 Sekisui Medical Co., Ltd
- 8.5.1 Sekisui Medical Co., Ltd Company Information
- 8.5.2 Sekisui Medical Co., Ltd Business Overview
- 8.5.3 Sekisui Medical Co., Ltd Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Sekisui Medical Co., Ltd Therapeutic Drug Monitoring Consumables Product Portfolio
- 8.5.5 Sekisui Medical Co., Ltd Recent Developments
- 8.6 Exagen Inc
- 8.6.1 Exagen Inc Company Information
- 8.6.2 Exagen Inc Business Overview
- 8.6.3 Exagen Inc Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Exagen Inc Therapeutic Drug Monitoring Consumables Product Portfolio
- 8.6.5 Exagen Inc Recent Developments
- 8.7 Danaher Corporation
- 8.7.1 Danaher Corporation Company Information
- 8.7.2 Danaher Corporation Business Overview
- 8.7.3 Danaher Corporation Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Danaher Corporation Therapeutic Drug Monitoring Consumables Product Portfolio
- 8.7.5 Danaher Corporation Recent Developments
- 8.8 Bio-Rad Laboratories
- 8.8.1 Bio-Rad Laboratories Company Information
- 8.8.2 Bio-Rad Laboratories Business Overview
- 8.8.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Bio-Rad Laboratories Therapeutic Drug Monitoring Consumables Product Portfolio
- 8.8.5 Bio-Rad Laboratories Recent Developments
- 8.9 bioMérieux SA
- 8.9.1 bioMérieux SA Company Information
- 8.9.2 bioMérieux SA Business Overview
- 8.9.3 bioMérieux SA Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 bioMérieux SA Therapeutic Drug Monitoring Consumables Product Portfolio
- 8.9.5 bioMérieux SA Recent Developments
- 8.10 Alere, Inc.
- 8.10.1 Alere, Inc. Company Information
- 8.10.2 Alere, Inc. Business Overview
- 8.10.3 Alere, Inc. Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Alere, Inc. Therapeutic Drug Monitoring Consumables Product Portfolio
- 8.10.5 Alere, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Therapeutic Drug Monitoring Consumables Value Chain Analysis
- 9.1.1 Therapeutic Drug Monitoring Consumables Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Therapeutic Drug Monitoring Consumables Production Mode & Process
- 9.2 Therapeutic Drug Monitoring Consumables Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Therapeutic Drug Monitoring Consumables Distributors
- 9.2.3 Therapeutic Drug Monitoring Consumables Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst